Parlodel
Parlodel
- Parlodel (bromocriptine) is sold in pharmacies worldwide; it is formally a prescription (Rx) medicine in nearly all countries, but some pharmacies may supply it without a receipt — check local regulations and always follow national prescription laws.
- Parlodel is used for hyperprolactinemia, acromegaly, Parkinson’s disease and, as Cycloset in the USA, for type 2 diabetes; it is a dopamine D2 receptor agonist that suppresses prolactin (and can reduce growth hormone), improves dopaminergic tone in the CNS and can affect glucose metabolism.
- Usual adult doses vary by condition: hyperprolactinemia start 1.25–2.5 mg once or twice daily (maintenance up to ~7.5 mg/day, max ~15 mg/day); acromegaly start 1.25–2.5 mg qd/bid with titration (maintenance up to 20 mg/day, max ~30 mg/day); Parkinson’s often start 1.25 mg qd/bid titrated to typical ranges 10–40 mg/day; Cycloset dosing for diabetes starts 0.8 mg qd, titrated to 1.6–4.8 mg/day (max 4.8 mg/day).
- Parlodel is administered orally as a tablet (commonly 2.5 mg; 5 mg tablets available in some countries).
- Bromocriptine begins to lower prolactin within hours; symptomatic or clinical improvements may be noticed over days to weeks depending on the indication.
- The drug has a relatively short plasma half‑life (approximately 2–8 hours); clinical effect is maintained with appropriate daily or divided dosing as prescribed.
- Avoid or minimise alcohol while taking parlodel, as alcohol can increase dizziness, sedation and the risk of orthostatic hypotension.
- The most common side effect is nausea.
- Would you like to try parlodel without a prescription?
Basic Parlodel Information
- INN (International Nonproprietary Name): Bromocriptine
- Brand Names Available In Canada (English): Parlodel (brand available worldwide); other brand names noted in source material include Parlodel Sandoz, Bromocriptin-ratiopharm and Cycloset (US) — availability in Canada not specified
- ATC Code: G02CB01 (Bromocriptine)
- Forms & Dosages: Tablets, commonly 2.5 mg; 5 mg tablets occur in some countries but are not universal
- Manufacturers In Canada (English): not specified
- Registration Status In Canada (English): not specified
- OTC / Rx Classification: Rx only (prescription required in nearly all markets)
Initial Instructions, Warnings & Daily-Life Integration
Worried about storing and using Parlodel safely at home?
Read labels and keep Parlodel (bromocriptine) in the original packaging at room temperature, away from moisture and heat.
Store the medication out of reach of children.
Health Canada requires a prescription and a Drug Identification Number (DIN) on marketed products; check the tablet strength (commonly 2.5 mg) before use.
Do not drive or operate heavy machinery until you know how you react, because orthostatic hypotension and dizziness are common, especially during titration.
If you live in rural Canada, plan pharmacy refills ahead because mail-order or provincial pharmacy networks may add delays.
Carry a concise medication card with the drug name, dose, prescriber, and an emergency contact, and tell any emergency providers you take an ergot alkaloid.
For questions about breastfeeding or pregnancy, contact your prescriber or provincial teratology information services.
Seek emergency care for sudden chest pain, severe headache, fainting, hallucinations, or high fever.
Morning Vs Evening Dosing In Canadian Routines
Which time of day works best depends on your prescription and tolerance.
Many Canadians take the first dose in the morning with breakfast to reduce nausea and to match primary care or specialist clinic hours for follow-up.
If prescribed once daily for hyperprolactinemia, morning dosing often makes work and clinic monitoring easier.
For Parkinson’s disease or higher-dose regimens, specialists commonly split doses according to symptom control and tolerance.
When dose escalation causes orthostatic symptoms on standing, pause for 1–2 minutes before standing and hydrate.
Rural patients should coordinate dose times with travel plans for lab draws to check prolactin or blood pressure.
Taking With Or Without Meals (Canadian Diet Context)
Can food make nausea better or worse?
Taking Parlodel immediately after a light meal, such as toast or yogurt, often reduces gastric upset when treatment starts.
Avoid very heavy, fried breakfasts if you find them more likely to trigger nausea during initiation.
If nausea persists, talk to your pharmacist about antiemetic options or dosing adjustments.
Caffeine can increase jitteriness for some patients, so monitor how coffee, tea or energy drinks affect side effects.
- Timing Tips: Start with morning dosing with breakfast where possible; match clinic hours for early review; split doses only if prescribed for Parkinson’s or high-dose regimens.
- Nausea Mitigation Checklist: Take with light food, try crackers before dosing, discuss antiemetic or dosing changes with your pharmacist, stand up slowly to avoid dizziness.
Safety Priorities
Who should not take Parlodel, and what activities need caution?
Who Should Avoid It (Health Canada Advisories)
Absolute contraindications include uncontrolled hypertension, known hypersensitivity to ergot derivatives, and certain postpartum conditions such as pre-eclampsia or eclampsia.
People with active severe psychotic disorders should avoid bromocriptine because dopamine agonists can worsen psychosis.
Prescribers must weigh cardiovascular disease, hepatic or renal impairment, and history of peptic ulcer disease as relative cautions.
Elderly patients require low-start titration due to higher risks of hypotension and confusion.
Activities To Limit (Driving, Workplace Safety)
Activities requiring alertness should be limited during initiation and any dose escalation until individual effects are known.
Do not drive, operate heavy machinery, or perform safety-sensitive work if you experience dizziness or orthostatic hypotension.
Provincially regulated workplaces in Ontario, British Columbia and other provinces may require occupational health documentation for work restrictions.
Report serious adverse effects to your pharmacist or to Health Canada’s vigilance system.
| Contraindication / Precaution | Why It Matters |
|---|---|
| Uncontrolled Hypertension | Risk of cardiovascular events and contraindication to therapy |
| Severe Psychotic Disorders | Dopamine agonists can worsen psychosis |
| Hypersensitivity To Ergot Alkaloids | Allergic reactions or severe intolerance |
| Postpartum With Pre-Eclampsia/Eclampsia | Increased cardiovascular risk; contraindicated |
- Activities To Avoid: Driving or heavy machinery during initiation; safety-sensitive work until stable; alcohol when dizzy.
Dosage & Adjustments
How should Parlodel be dosed, and what to watch for when doses change?
General Regimen (DIN References)
Standard starting doses for adults with hyperprolactinemia are 1.25–2.5 mg once or twice daily, with maintenance up to about 7.5 mg per day and a typical maximum of 15 mg per day for that indication.
For acromegaly, specialists start low and titrate up; some regimens may reach higher doses with specialist supervision.
Parkinson’s disease regimens typically begin at 1.25 mg once or twice daily, titrating according to response; specialist doses for Parkinson’s can be markedly higher and are individualized.
Confirm the product’s Drug Identification Number (DIN) and tablet strength (commonly 2.5 mg) on the label when dispensing in Canada.
Special Cases (Elderly, Comorbidities)
Elderly patients should start at low doses, for example 1.25 mg daily, with slow titration and frequent blood pressure monitoring to reduce orthostatic hypotension risk.
Hepatic or renal impairment has no formal Canada-wide dosing change listed, but prescribers commonly start lower and monitor closely for adverse reactions.
Children should receive bromocriptine only under specialist paediatric endocrine or neurology supervision with individualised dosing.
Missed-dose advice: take when remembered unless it is close to the next dose, do not double the next dose.
Overdose may cause vomiting, hypotension, hallucinations or arrhythmia and requires immediate medical attention.
| Indication | Typical Starting Dose | Typical Maintenance / Max |
|---|---|---|
| Hyperprolactinemia | 1.25–2.5 mg qd/bid | Up to 7.5 mg/day; max 15 mg/day |
| Acromegaly | 1.25–2.5 mg qd/bid | Gradual titration; up to 20–30 mg/day in specialist care |
| Parkinson’s Disease | 1.25 mg qd/bid, titrate | Usual specialist ranges 10–40 mg/day; rare specialist regimens higher |
- Monitoring Checklist: Baseline and periodic blood pressure (sitting and standing), baseline prolactin where indicated, mental status checks, liver/renal labs if comorbidities exist.
User Testimonials
What are Canadians saying about Parlodel in real life forums and clinic conversations?
Positive Reports From Canadian Patients
Many Canadian patients report fast improvement in galactorrhea and menstrual irregularities at low bromocriptine doses with specialist oversight.
Some women describe restored fertility plans after prolactin normalisation under care of an endocrine specialist.
For Parkinson’s adjunctive use, individual reports vary; some patients notice motor symptom benefit when bromocriptine is part of a broader regimen.
Common Challenges In Forums (Reddit Canada, Health Boards)
Initial nausea and dizziness during titration are frequent topics in Reddit Canada threads and provincial health boards.
Coverage and reimbursement challenges are commonly discussed, as are pharmacy stock issues for rural communities.
Practical coping strategies reported include taking the tablet with crackers, standing slowly after sitting, and timing doses around lab appointments to avoid missed draws.
Readers should remember that forum anecdotes do not replace prescriber advice and that adverse events should be reported to a pharmacist or to Health Canada’s Canada Vigilance Program.
| Pros (Anecdotal) | Cons (Anecdotal) |
|---|---|
| Rapid reduction in galactorrhea and prolactin-related symptoms | Nausea and orthostatic dizziness during initiation |
| Low-cost generics available in many markets | Coverage gaps and rural stock shortages |
- Patient Tips: Pre-dose crackers or toast, hydrate and stand slowly, coordinate refills early if living rurally.
Buying Guide
Where can Parlodel be obtained in Canada and what should patients expect on price and access?
Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)
Parlodel and bromocriptine generics are prescription-only and are dispensed by national chains such as Shoppers Drug Mart, Rexall and London Drugs and by regional chains such as Jean Coutu in Quebec.
Independent and hospital pharmacies also dispense generics; ask your pharmacist for bromocriptine mesylate 2.5 mg tablets by generic name if preferred.
Our online pharmacy offers discreet delivery options within Canada.
Price Comparison (In-Store Vs Online, Cross-Border Notes)
Prices vary across provinces and depend on provincial drug programs and pharmacy pricing policies.
Check provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ for coverage criteria before assuming out-of-pocket costs.
Ordering from US online sources may expose packages to customs and will not provide a Canadian DIN or Health Canada oversight, so it is not recommended for continuity of care.
Mail-order and specialty pharmacy services can help rural patients maintain supply if local stock is inconsistent.
| Source | What To Check |
|---|---|
| National Chains (Shoppers, Rexall) | Confirm DIN, tablet strength, and provincial coverage rules |
| Regional Chains (Jean Coutu, London Drugs) | Ask about generics and special-authority paperwork for coverage |
| Online Pharmacies (Canadian) | Require valid prescription and DIN verification; expect 5–14 day delivery windows |
- Safe Online Purchase Checklist: Ensure the pharmacy asks for a valid prescription, verify the DIN and manufacturer, confirm Canadian delivery and returns policy.
In our online pharmacy, parlodel is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
What’s Inside & How It Works
What is bromocriptine made of and how does it act in the body?
Ingredients Overview
The active ingredient is bromocriptine, commonly formulated as bromocriptine mesylate in tablets of 2.5 mg strength.
Excipients differ by manufacturer; check blister packs and package inserts for any allergy-relevant ingredients and for bilingual labelling in English and French in Canada.
Mechanism Basics
Bromocriptine is a dopamine D2 receptor agonist that suppresses prolactin secretion from the pituitary gland.
It can reduce growth hormone secretion in some patients with acromegaly and improves dopaminergic tone in the central nervous system for Parkinson’s disease adjunctive therapy.
As an ergot derivative, vascular and cardiac considerations apply and clinicians may prefer cabergoline in many cases because of its longer half-life and improved tolerability.
| Mechanism | Indication | Expected Effect |
|---|---|---|
| Dopamine D2 Agonist | Hyperprolactinemia | Decreased prolactin levels and symptom relief |
| Dopamine Agonist | Parkinson’s Disease (Adjunct) | Improved dopaminergic tone and motor function support |
| Dopamine Agonist | Acromegaly | Lowered growth hormone secretion in some patients |
Main Indications
When do clinicians use Parlodel, and when might they try other options?
Approved Uses In Canada
Bromocriptine is approved in most countries for hyperprolactinemia, acromegaly and as adjunctive therapy in Parkinson’s disease, though local product monographs and provincial formularies determine specific marketed indications.
In clinical practice, bromocriptine is commonly used for prolactin-related infertility and symptomatic hyperprolactinemia with monitoring.
Off-Label Uses By Canadian Physicians
Off-label uses noted in research contexts include investigations into metabolic syndrome and certain refractory headaches, but evidence is less established and specialist input is important.
Cabergoline often supersedes bromocriptine for chronic hyperprolactinemia due to fewer side effects and less frequent dosing, but clinicians may select bromocriptine for cost, availability or individual tolerance.
| Indication | Typical Starting Dose | Monitoring |
|---|---|---|
| Hyperprolactinemia | 1.25–2.5 mg once or twice daily | Baseline and follow-up prolactin, BP monitoring |
| Acromegaly | 1.25–2.5 mg qd/bid with titration | GH and IGF-1 levels, cardiac monitoring if indicated |
| Parkinson’s (Adjunct) | 1.25 mg qd/bid with specialist titration | Motor function review and mental status checks |
Interaction Warnings
Which foods, supplements and drugs interact with bromocriptine?
Food Interactions (Alcohol, Caffeine)
Alcohol can worsen dizziness, hypotension and sedation with bromocriptine, so limit intake during initiation and when doses change.
Caffeine may increase jitteriness in some people but does not cause a clinically significant pharmacokinetic interaction.
Drug Conflicts (Health Canada Database)
Check the Health Canada Drug Product Database for specific warnings, but general interactions include potentiation of orthostatic hypotension with antihypertensives.
Combining bromocriptine with other dopamine agonists or antagonists, such as antipsychotics, can reduce efficacy or precipitate psychiatric effects.
Strong CYP3A4 inhibitors or interacting agents can alter bromocriptine exposure and warrant pharmacist review and possible monitoring.
Always provide a full medication list, including OTC and herbal products like St. John’s Wort, to your pharmacist before starting therapy.
- Interaction Checklist: Avoid alcohol around initiation, report all prescription and OTC meds, check antidepressants and antipsychotics with your pharmacist, and consult Health Canada database entries when in doubt.
Latest Evidence & Insights
What does research say about bromocriptine and how does that affect patients here?
Highlight Canadian And International Research
Clinical trials and reviews indicate bromocriptine effectively suppresses prolactin, especially at low starting doses, but side-effect profiles often make cabergoline a preferred first-line agent for many clinicians.
International studies and some Canadian series show rapid prolactin reduction within days, while symptomatic improvement may take weeks.
There is growing interest in metabolic effects of bromocriptine, particularly formulations developed for glycaemic control in the US market under the name Cycloset, but Health Canada indications differ and evidence for metabolic indications remains evolving.
| Study Type | Population | Key Outcome |
|---|---|---|
| Randomized Trials | Patients with hyperprolactinemia | Prolactin reduction seen rapidly; side effects common during titration |
| Observational | Parkinson’s adjunct cohorts | Motor benefit variable; higher CNS adverse events in elderly |
| Metabolic Research | Type 2 diabetes formulations (Cycloset) | Modest glycaemic effects for specific formulations, more research needed |
- Practical Takeaways: Start low and titrate slowly, monitor BP and mental status, consider switching to cabergoline if long-term tolerance is poor.
Alternative Choices
What are reasonable alternatives to Parlodel and when should patients consider switching?
List Of Comparable Medicines With Pros/Cons Checklist
Common alternatives include cabergoline (Dostinex, Cabaser), which has a longer half-life and generally better tolerability for hyperprolactinemia.
Quinagolide (Norprolac) is another non-ergot option used in some countries for hyperprolactinemia.
For Parkinson’s disease, several dopamine agonists and levodopa-based regimens are available and selection is specialist-driven.
- Cabergoline: Fewer daily doses and less nausea but may require cardiac valve monitoring and can be costlier.
- Bromocriptine: Lower cost, widely available generics, but more frequent dosing and higher incidence of GI side effects.
When To Consider Switching (Provincial Formulary Notes)
Consider switching when side effects are intolerable, biochemical control is inadequate, pregnancy is planned, or formulary coverage changes.
Provincial formularies may require special authorization to cover cabergoline or other alternatives, so check ODB, PharmaCare or RAMQ rules before making changes.
Switching should be managed by your prescriber and pharmacist with an agreed washout or cross-titration and monitoring plan.
Regulation Snapshot
How is bromocriptine regulated and what does that mean for patients in Canada?
Health Canada Approval And DIN Requirements
Bromocriptine products sold legally in Canada must be authorized by Health Canada and bear a Drug Identification Number (DIN) for lawful distribution.
Confirm the DIN on any Canadian-packaged product and check the product monograph when in doubt.
Provincial Drug Plan Implications (ODP, PharmaCare, RAMQ)
Provincial drug plans differ in coverage criteria and some require special authority or specific indications for reimbursement.
Patients should check Ontario Drug Benefit, BC PharmaCare and RAMQ formularies for coverage rules and discuss with prescribers and pharmacists when planning therapy.
Report adverse reactions through Canada Vigilance and keep pharmacy records of counselling and dispensing for auditability.
| Regulatory Item | Patient Action |
|---|---|
| DIN Verification | Check the product label for the DIN before filling |
| Provincial Coverage | Confirm formulary rules and special-authority needs with prescriber/pharmacist |
| Adverse Event Reporting | Report to pharmacist and Canada Vigilance if serious |
FAQ Section
Short answers to common patient questions about Parlodel.
Common Patient Questions
Q: Can I breastfeed on Parlodel?
A: Bromocriptine suppresses lactation and is not suitable if breastfeeding is desired; discuss alternatives with your clinician.
Q: How quickly does it work?
A: Prolactin levels often fall within days, while symptom improvement may take weeks.
Q: Is a follow-up lab needed?
A: Yes; prescribers commonly order prolactin tests and monitor blood pressure, with further tests as clinically indicated.
Q: Can I stop suddenly?
A: Do not stop abruptly without clinician guidance because rebound symptoms can occur; tapering may be needed under supervision.
When To Call Your Prescriber Or Pharmacist
Contact your prescriber or local pharmacist promptly for severe dizziness, fainting, chest pain, hallucinations, sudden vision changes, or signs of thromboembolism.
For non-urgent side effects like mild nausea or constipation, your pharmacist can advise supportive measures or recommend an antiemetic if appropriate.
- Red-Flag Symptoms: Chest pain, sudden severe headache, fainting spells, high fever, hallucinations, or sudden vision loss.
- Contact Card Template: Drug: Parlodel (bromocriptine) — Dose: [insert] — Prescriber: [name, phone] — Pharmacy: [name, phone] — Emergency Contact: [name, phone].
Guidelines For Proper Use
What Canadian pharmacists and health authorities recommend for safe use and follow-up.
Canadian Pharmacist And Provincial Health Authority Recommendations
Pharmacists should confirm the indication, review interactions, counsel on orthostatic precautions and verify the DIN and strength before dispensing.
Provincial bodies recommend baseline blood pressure, pregnancy test where relevant, and baseline prolactin measurement prior to starting therapy.
Provide bilingual information (English/French) and document counselling in pharmacy records for continuity and provincial auditability.
Follow-Up Schedule And Monitoring Checklist
A typical follow-up schedule might include a clinic or pharmacy check within 1–4 weeks of initiation, prolactin recheck at 4–12 weeks, and periodic reviews thereafter for long-term therapy.
Monitoring checklist items include baseline and periodic prolactin, blood pressure sitting and standing, mental status review for hallucinations or confusion, liver and renal function where comorbidities are present, and ECG if clinically indicated at higher doses or with cardiac history.
| Timepoint | Action |
|---|---|
| Baseline | Prolactin, BP sitting & standing, pregnancy test if relevant |
| 1–4 Weeks | Symptom check, BP and side-effect review |
| 4–12 Weeks | Repeat prolactin and adjust dose as needed |
| Ongoing | Periodic prolactin, BP, mental status, and organ function monitoring as indicated |
- Printable Monitoring Checklist: Baseline labs, BP checks, mental status review, refill reminders, and specialist coordination for acromegaly or Parkinson’s management.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |